Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 14 open reading frame 132 (C14orf132) is a protein-coding gene in humans. It is predicted to be membrane-associated, but its precise biological function is currently uncharacterized. While omics and bioinformatic studies have implicated its alteration in some cancer types (such as lung non-small cell carcinoma and hepatocellular carcinoma), there is no evidence of it being a therapeutic target, nor are there reports of drugs that interact with it directly. The gene may play roles linked to disease pathology via broad cellular mechanisms, but no specific molecular function or pathway assignment has been established in the literature[1][2][3][5][7][10][11].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 14 open reading frame 132 (C14orf132).